English

NEWLINK GENETICS CORP

EDGAR

LUMO Quarterly report (10-Q) · filed 2024-11-07

104 filing records in this dataset, filed from 2010-12-21 to 2024-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

726 thousand USD

2024 Q4 · USD

Exact inputs and evidence

Revenue: 726000 USD Source

Operating margin

-1,052.34%

2024 Q4 · %

Exact inputs and evidence

Operating Income: -7640000 USD Source
Revenue: 726000 USD Source

Operating cash flow

-5.01 million USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -24280000 USD Source
Operating Cash Flow: -19274000 USD Source

Cash and cash equivalents: 13.5 million USD 2024-09-30 Source
Exact value

13500000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 8.65 million shares 2024-09-30 Source
Exact value

8648243 shares

Reported share-count change

9.27% · 734 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

7914582 shares · 2023-09-30· Source
8648243 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.21 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Revenue: 2051000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 1225000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 165000 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 488000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 726000 USD · 2024-07-01 – 2024-09-30 Source

Net income

-34.9 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Net income: -34034000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -24577000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -10441000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -7551000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -7467000 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-31.7 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Operating cash flow: -31095000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -23702000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -12894000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -19274000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -12894000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -24280000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -19274000 USD · 2024-01-01 – 2024-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-07.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2023-12-31
Net income: 11 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2023-12-31
Capital expenditure: 7 of 11 periods available· newest 2019-12-31
Total assets: 11 of 11 periods available· newest 2023-12-31
Total liabilities: 11 of 11 periods available· newest 2023-12-31
Current assets: 11 of 11 periods available· newest 2023-12-31
Current liabilities: 11 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+34.7%

Prior period

USD 1.52 million

2022-01-01 – 2022-12-31
Current period

USD 2.05 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

2051000 − 1523000 = 528000 USD

1523000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
2051000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEWLINK GENETICS CORP · 2023-12-31 NEWLINK GENETICS CORP (edgar:1126234) Year-over-year change in Revenue: 528000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2051000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#881768 Filing: 000112623424000025 Input fundies:Revenue: 1523000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#882310 Filing: 000112623424000025
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 2.97 million

Prior period

−USD 31.06 million

2022-01-01 – 2022-12-31
Current period

−USD 34.03 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-34034000 − -31062000 = -2972000 USD

-31062000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-34034000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEWLINK GENETICS CORP · 2023-12-31 NEWLINK GENETICS CORP (edgar:1126234) Year-over-year change in Net income: -2972000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34034000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1386474 Filing: 000112623424000025 Input fundies:NetIncome: -31062000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1387400 Filing: 000112623424000025
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 4.47 million

Prior period

−USD 26.62 million

2022-01-01 – 2022-12-31
Current period

−USD 31.1 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-31095000 − -26623000 = -4472000 USD

-26623000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-31095000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEWLINK GENETICS CORP · 2023-12-31 NEWLINK GENETICS CORP (edgar:1126234) Year-over-year change in Operating cash flow: -4472000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31095000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1051155 Filing: 000112623424000025 Input fundies:OperatingCashFlow: -26623000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1051811 Filing: 000112623424000025
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2023-01-01 – 2023-12-31

Revenue USD 2.05 million 100% of revenue
Operating costs Derived USD 38.67 million 1,885% of revenue
Operating income −USD 36.61 million −1,785% of revenue
Tax, interest and other Derived −USD 2.58 million −126% of revenue
Net income −USD 34.03 million −1,659% of revenue

Cash

Operating cash flow −USD 31.1 million −1,516% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 56%12%32%
2016 Operating loss: operating costs were 149% of revenue.
2017 Operating loss: operating costs were 354% of revenue.
2018 Operating loss: operating costs were 354% of revenue.
2019 Operating loss: operating costs were 601% of revenue.
2020 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 15,757% of revenue.
2022 Operating loss: operating costs were 13,729% of revenue.
2023 Operating loss: operating costs were 2,204% of revenue.
2024 Operating loss: operating costs were 1,885% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2014-01-01 – 2014-12-31	172592000	55019000 Derived	117573000	21556000 Derived	96017000	107368000 Derived	Source 2014-01-01 – 2014-12-31: 172592000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 117573000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 96017000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 109068000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 1700000 USD Inspect Capital Expenditure Open source
2016 2015-01-01 – 2015-12-31	68501000	102103000 Derived	-33602000	6779000 Derived	-40381000	-28082000 Derived	Source 2015-01-01 – 2015-12-31: 68501000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -33602000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -40381000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -24087000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 3995000 USD Inspect Capital Expenditure Open source
2017 2016-01-01 – 2016-12-31	35800000	126558000 Derived	-90758000	-5603000 Derived	-85155000	-68193000 Derived	Source 2016-01-01 – 2016-12-31: 35800000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -90758000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -85155000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -65947000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 2246000 USD Inspect Capital Expenditure Open source
2018 2017-01-01 – 2017-12-31	28711000	101592000 Derived	-72881000	-930000 Derived	-71951000	-48324000 Derived	Source 2017-01-01 – 2017-12-31: 28711000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -72881000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -71951000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -48281000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 43000 USD Inspect Capital Expenditure Open source
2019 2018-01-01 – 2018-12-31	12474000	74912000 Derived	-62438000	-8843000 Derived	-53595000	-37946000 Derived	Source 2018-01-01 – 2018-12-31: 12474000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -62438000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -53595000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -37939000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 7000 USD Inspect Capital Expenditure Open source
2020 2019-01-01 – 2019-12-31	0	9816000 Derived	-9816000	-111000 Derived	-9705000	-9090000 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -9816000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -9705000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -9090000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source
2021 2020-01-01 – 2020-12-31	168000	26471000 Derived	-26303000	-20640000 Derived	-5663000	Unavailable	Source 2020-01-01 – 2020-12-31: 168000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -26303000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -5663000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -22997000 USD Inspect Operating Cash Flow Open source
2022 2021-01-01 – 2021-12-31	230000	31577000 Derived	-31347000	-917000 Derived	-30430000	Unavailable	Source 2021-01-01 – 2021-12-31: 230000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -31347000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -30430000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -29648000 USD Inspect Operating Cash Flow Open source
2023 2022-01-01 – 2022-12-31	1523000	33563000 Derived	-32040000	-978000 Derived	-31062000	Unavailable	Source 2022-01-01 – 2022-12-31: 1523000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -32040000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -31062000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -26623000 USD Inspect Operating Cash Flow Open source
2024 2023-01-01 – 2023-12-31	2051000	38665000 Derived	-36614000	-2580000 Derived	-34034000	Unavailable	Source 2023-01-01 – 2023-12-31: 2051000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -36614000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -34034000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -31095000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.1M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152014-12-31	Revenue	172592000	Revenue: 172592000 Open source
20162015-12-31	Revenue	68501000	Revenue: 68501000 Open source
20172016-12-31	Revenue	35800000	Revenue: 35800000 Open source
20182017-12-31	Revenue	28711000	Revenue: 28711000 Open source
20192018-12-31	Revenue	12474000	Revenue: 12474000 Open source
20202019-12-31	Revenue	0	Revenue: 0 Open source
20212020-12-31	Revenue	168000	Revenue: 168000 Open source
20222021-12-31	Revenue	230000	Revenue: 230000 Open source
20232022-12-31	Revenue	1523000	Revenue: 1523000 Open source
20242023-12-31	Revenue	2051000	Revenue: 2051000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

34.7% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152014-12-31	Year over year	15,690.7%	Revenue: 172592000 Open source Revenue: 1093000 Open source
20162015-12-31	Year over year	-60.3%	Revenue: 68501000 Open source Revenue: 172592000 Open source
20172016-12-31	Year over year	-47.7%	Revenue: 35800000 Open source Revenue: 68501000 Open source
20182017-12-31	Year over year	-19.8%	Revenue: 28711000 Open source Revenue: 35800000 Open source
20192018-12-31	Year over year	-56.6%	Revenue: 12474000 Open source Revenue: 28711000 Open source
20202019-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 12474000 Open source
20212020-12-31	Year over year	No prior comparable period	Revenue: 168000 Open source Revenue: 0 Open source
20222021-12-31	Year over year	36.9%	Revenue: 230000 Open source Revenue: 168000 Open source
20232022-12-31	Year over year	562.2%	Revenue: 1523000 Open source Revenue: 230000 Open source
20242023-12-31	Year over year	34.7%	Revenue: 2051000 Open source Revenue: 1523000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,785.2% 2024

Net margin -1,659.4% 2024

Free cash flow margin -304.2% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152014-12-31	Operating margin	68.1%	Operating Income: 117573000 Open source Revenue: 172592000 Open source
20162015-12-31	Operating margin	-49.1%	Operating Income: -33602000 Open source Revenue: 68501000 Open source
20172016-12-31	Operating margin	-253.5%	Operating Income: -90758000 Open source Revenue: 35800000 Open source
20182017-12-31	Operating margin	-253.8%	Operating Income: -72881000 Open source Revenue: 28711000 Open source
20192018-12-31	Operating margin	-500.5%	Operating Income: -62438000 Open source Revenue: 12474000 Open source
20202019-12-31	Operating margin	Not reported	Operating Income: -9816000 Open source Revenue: 0 Open source
20212020-12-31	Operating margin	-15,656.5%	Operating Income: -26303000 Open source Revenue: 168000 Open source
20222021-12-31	Operating margin	-13,629.1%	Operating Income: -31347000 Open source Revenue: 230000 Open source
20232022-12-31	Operating margin	-2,103.7%	Operating Income: -32040000 Open source Revenue: 1523000 Open source
20242023-12-31	Operating margin	-1,785.2%	Operating Income: -36614000 Open source Revenue: 2051000 Open source
20152014-12-31	Net margin	55.6%	Net Income: 96017000 Open source Revenue: 172592000 Open source
20162015-12-31	Net margin	-58.9%	Net Income: -40381000 Open source Revenue: 68501000 Open source
20172016-12-31	Net margin	-237.9%	Net Income: -85155000 Open source Revenue: 35800000 Open source
20182017-12-31	Net margin	-250.6%	Net Income: -71951000 Open source Revenue: 28711000 Open source
20192018-12-31	Net margin	-429.7%	Net Income: -53595000 Open source Revenue: 12474000 Open source
20202019-12-31	Net margin	Not reported	Net Income: -9705000 Open source Revenue: 0 Open source
20212020-12-31	Net margin	-3,370.8%	Net Income: -5663000 Open source Revenue: 168000 Open source
20222021-12-31	Net margin	-13,230.4%	Net Income: -30430000 Open source Revenue: 230000 Open source
20232022-12-31	Net margin	-2,039.5%	Net Income: -31062000 Open source Revenue: 1523000 Open source
20242023-12-31	Net margin	-1,659.4%	Net Income: -34034000 Open source Revenue: 2051000 Open source
20152014-12-31	Free cash flow margin	62.2%	Revenue: 172592000 Open source Operating Cash Flow: 109068000 Open source Capital Expenditure: 1700000 Open source
20162015-12-31	Free cash flow margin	-41%	Revenue: 68501000 Open source Operating Cash Flow: -24087000 Open source Capital Expenditure: 3995000 Open source
20172016-12-31	Free cash flow margin	-190.5%	Revenue: 35800000 Open source Operating Cash Flow: -65947000 Open source Capital Expenditure: 2246000 Open source
20182017-12-31	Free cash flow margin	-168.3%	Revenue: 28711000 Open source Operating Cash Flow: -48281000 Open source Capital Expenditure: 43000 Open source
20192018-12-31	Free cash flow margin	-304.2%	Revenue: 12474000 Open source Operating Cash Flow: -37939000 Open source Capital Expenditure: 7000 Open source
20202019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9090000 Open source Capital Expenditure: 0 Open source
20212020-12-31	Free cash flow margin	Not reported	Revenue: 168000 Open source Operating Cash Flow: -22997000 Open source
20222021-12-31	Free cash flow margin	Not reported	Revenue: 230000 Open source Operating Cash Flow: -29648000 Open source
20232022-12-31	Free cash flow margin	Not reported	Revenue: 1523000 Open source Operating Cash Flow: -26623000 Open source
20242023-12-31	Free cash flow margin	Not reported	Revenue: 2051000 Open source Operating Cash Flow: -31095000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -31.1M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152014-12-31	Operating cash flow	109068000	Operating Cash Flow: 109068000 Open source
20162015-12-31	Operating cash flow	-24087000	Operating Cash Flow: -24087000 Open source
20172016-12-31	Operating cash flow	-65947000	Operating Cash Flow: -65947000 Open source
20182017-12-31	Operating cash flow	-48281000	Operating Cash Flow: -48281000 Open source
20192018-12-31	Operating cash flow	-37939000	Operating Cash Flow: -37939000 Open source
20202019-12-31	Operating cash flow	-9090000	Operating Cash Flow: -9090000 Open source
20212020-12-31	Operating cash flow	-22997000	Operating Cash Flow: -22997000 Open source
20222021-12-31	Operating cash flow	-29648000	Operating Cash Flow: -29648000 Open source
20232022-12-31	Operating cash flow	-26623000	Operating Cash Flow: -26623000 Open source
20242023-12-31	Operating cash flow	-31095000	Operating Cash Flow: -31095000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9.1M 2020

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152014-12-31	Free cash flow	107368000	Operating Cash Flow: 109068000 Open source Capital Expenditure: 1700000 Open source
20162015-12-31	Free cash flow	-28082000	Operating Cash Flow: -24087000 Open source Capital Expenditure: 3995000 Open source
20172016-12-31	Free cash flow	-68193000	Operating Cash Flow: -65947000 Open source Capital Expenditure: 2246000 Open source
20182017-12-31	Free cash flow	-48324000	Operating Cash Flow: -48281000 Open source Capital Expenditure: 43000 Open source
20192018-12-31	Free cash flow	-37946000	Operating Cash Flow: -37939000 Open source Capital Expenditure: 7000 Open source
20202019-12-31	Free cash flow	-9090000	Operating Cash Flow: -9090000 Open source Capital Expenditure: 0 Open source
20212020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22997000 Open source
20222021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -29648000 Open source
20232022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -26623000 Open source
20242023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -31095000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

32.8% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152014-12-31	Liabilities / assets	14.8%	Total Liabilities: 34285000 Open source Total Assets: 231221000 Open source
20162015-12-31	Liabilities / assets	10.4%	Total Liabilities: 22768000 Open source Total Assets: 218542000 Open source
20172016-12-31	Liabilities / assets	25.9%	Total Liabilities: 45281000 Open source Total Assets: 174747000 Open source
20182017-12-31	Liabilities / assets	16.1%	Total Liabilities: 29140000 Open source Total Assets: 180697000 Open source
20192018-12-31	Liabilities / assets	12.1%	Total Liabilities: 15796000 Open source Total Assets: 130939000 Open source
20202019-12-31	Liabilities / assets	26.3%	Total Liabilities: 1454000 Open source Total Assets: 5526000 Open source
20212020-12-31	Liabilities / assets	9.7%	Total Liabilities: 12461000 Open source Total Assets: 129033000 Open source
20222021-12-31	Liabilities / assets	11.3%	Total Liabilities: 11335000 Open source Total Assets: 100312000 Open source
20232022-12-31	Liabilities / assets	17.6%	Total Liabilities: 12708000 Open source Total Assets: 72292000 Open source
20242023-12-31	Liabilities / assets	32.8%	Total Liabilities: 13333000 Open source Total Assets: 40638000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.69× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152014-12-31	Current assets / current liabilities	8.94×	Current Assets: 223622000 Open source Current Liabilities: 25021000 Open source
20162015-12-31	Current assets / current liabilities	14.03×	Current Assets: 208142000 Open source Current Liabilities: 14840000 Open source
20172016-12-31	Current assets / current liabilities	4.43×	Current Assets: 167912000 Open source Current Liabilities: 37905000 Open source
20182017-12-31	Current assets / current liabilities	7.96×	Current Assets: 175466000 Open source Current Liabilities: 22031000 Open source
20192018-12-31	Current assets / current liabilities	14.36×	Current Assets: 127072000 Open source Current Liabilities: 8847000 Open source
20202019-12-31	Current assets / current liabilities	4.01×	Current Assets: 5069000 Open source Current Liabilities: 1263000 Open source
20212020-12-31	Current assets / current liabilities	19.88×	Current Assets: 128449000 Open source Current Liabilities: 6461000 Open source
20222021-12-31	Current assets / current liabilities	19.43×	Current Assets: 99677000 Open source Current Liabilities: 5130000 Open source
20232022-12-31	Current assets / current liabilities	10.73×	Current Assets: 72009000 Open source Current Liabilities: 6708000 Open source
20242023-12-31	Current assets / current liabilities	5.69×	Current Assets: 40035000 Open source Current Liabilities: 7030000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2014-01-01 – 2014-12-31	USD 96.02 million Exact value Exact value: 96017000 USD 2014-01-01 – 2014-12-31: 96017000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2014-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: 96017000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 96017000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623417000025/nlnk-20161231.xml#147853 Filing: 000112623417000025 The citation records this snapshot. The page link may show a newer release later.	USD 109.07 million Exact value Exact value: 109068000 USD 2014-01-01 – 2014-12-31: 109068000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2014-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: 109068000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 109068000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623417000025/nlnk-20161231.xml#147097 Filing: 000112623417000025 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 million Exact value Exact value: 1700000 USD 2014-01-01 – 2014-12-31: 1700000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2014-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 1700000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1700000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623417000025/nlnk-20161231.xml#158123 Filing: 000112623417000025 The citation records this snapshot. The page link may show a newer release later.	USD 107.37 million Calculation and evidence 109068000 − 1700000 USD Exact free cash flow: 107368000 USD 2014-01-01 – 2014-12-31: 109068000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1700000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2014-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: 107368000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 109068000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623417000025/nlnk-20161231.xml#147097 Filing: 000112623417000025 Input fundies:CapitalExpenditure: 1700000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623417000025/nlnk-20161231.xml#158123 Filing: 000112623417000025 The citation records this snapshot. The page link may show a newer release later.
2016 2015-01-01 – 2015-12-31	−USD 40.38 million Exact value Exact value: -40381000 USD 2015-01-01 – 2015-12-31: -40381000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2015-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -40381000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40381000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623418000026/nlnk-20171231.xml#180048 Filing: 000112623418000026 The citation records this snapshot. The page link may show a newer release later.	−USD 24.09 million Exact value Exact value: -24087000 USD 2015-01-01 – 2015-12-31: -24087000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2015-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -24087000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24087000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623418000026/nlnk-20171231.xml#179412 Filing: 000112623418000026 The citation records this snapshot. The page link may show a newer release later.	USD 4 million Exact value Exact value: 3995000 USD 2015-01-01 – 2015-12-31: 3995000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2015-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 3995000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3995000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623418000026/nlnk-20171231.xml#189026 Filing: 000112623418000026 The citation records this snapshot. The page link may show a newer release later.	−USD 28.08 million Calculation and evidence -24087000 − 3995000 USD Exact free cash flow: -28082000 USD 2015-01-01 – 2015-12-31: -24087000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 3995000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2015-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: -28082000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24087000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623418000026/nlnk-20171231.xml#179412 Filing: 000112623418000026 Input fundies:CapitalExpenditure: 3995000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623418000026/nlnk-20171231.xml#189026 Filing: 000112623418000026 The citation records this snapshot. The page link may show a newer release later.
2017 2016-01-01 – 2016-12-31	−USD 85.16 million Exact value Exact value: -85155000 USD 2016-01-01 – 2016-12-31: -85155000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2016-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -85155000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -85155000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/nlnk-20181231.htm#2245268 Filing: 000112623419000026 The citation records this snapshot. The page link may show a newer release later.	−USD 65.95 million Exact value Exact value: -65947000 USD 2016-01-01 – 2016-12-31: -65947000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2016-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -65947000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65947000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/nlnk-20181231.htm#1652756 Filing: 000112623419000026 The citation records this snapshot. The page link may show a newer release later.	USD 2.25 million Exact value Exact value: 2246000 USD 2016-01-01 – 2016-12-31: 2246000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2016-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 2246000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2246000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/nlnk-20181231.htm#1661017 Filing: 000112623419000026 The citation records this snapshot. The page link may show a newer release later.	−USD 68.19 million Calculation and evidence -65947000 − 2246000 USD Exact free cash flow: -68193000 USD 2016-01-01 – 2016-12-31: -65947000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 2246000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2016-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: -68193000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -65947000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/nlnk-20181231.htm#1652756 Filing: 000112623419000026 Input fundies:CapitalExpenditure: 2246000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623419000026/nlnk-20181231.htm#1661017 Filing: 000112623419000026 The citation records this snapshot. The page link may show a newer release later.
2018 2017-01-01 – 2017-12-31	−USD 71.95 million Exact value Exact value: -71951000 USD 2017-01-01 – 2017-12-31: -71951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2017-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -71951000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71951000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#2404265 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	−USD 48.28 million Exact value Exact value: -48281000 USD 2017-01-01 – 2017-12-31: -48281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2017-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -48281000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48281000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1857477 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	USD 43,000 Exact value Exact value: 43000 USD 2017-01-01 – 2017-12-31: 43000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2017-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 43000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 43000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1863194 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	−USD 48.32 million Calculation and evidence -48281000 − 43000 USD Exact free cash flow: -48324000 USD 2017-01-01 – 2017-12-31: -48281000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 43000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2017-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: -48324000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48281000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1857477 Filing: 000112623420000018 Input fundies:CapitalExpenditure: 43000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1863194 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.
2019 2018-01-01 – 2018-12-31	−USD 53.6 million Exact value Exact value: -53595000 USD 2018-01-01 – 2018-12-31: -53595000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2018-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -53595000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53595000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#2402735 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	−USD 37.94 million Exact value Exact value: -37939000 USD 2018-01-01 – 2018-12-31: -37939000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2018-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -37939000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37939000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1856119 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2018-01-01 – 2018-12-31: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2018-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1861929 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	−USD 37.95 million Calculation and evidence -37939000 − 7000 USD Exact free cash flow: -37946000 USD 2018-01-01 – 2018-12-31: -37939000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2018-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: -37946000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37939000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1856119 Filing: 000112623420000018 Input fundies:CapitalExpenditure: 7000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1861929 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.
2020 2019-01-01 – 2019-12-31	−USD 9.71 million Exact value Exact value: -9705000 USD 2019-01-01 – 2019-12-31: -9705000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2019-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -9705000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9705000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623421000034/nlnk-20201231.htm#1525995 Filing: 000112623421000034 The citation records this snapshot. The page link may show a newer release later.	−USD 9.09 million Exact value Exact value: -9090000 USD 2019-01-01 – 2019-12-31: -9090000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2019-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -9090000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9090000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623421000034/nlnk-20201231.htm#1120905 Filing: 000112623421000034 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEWLINK GENETICS CORP · 2019-12-31 NEWLINK GENETICS CORP (edgar:1126234) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1860631 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.	−USD 9.09 million Calculation and evidence -9090000 − 0 USD Exact free cash flow: -9090000 USD 2019-01-01 – 2019-12-31: -9090000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEWLINK GENETICS CORP · 2019-12-31 NEWLINK GENETICS CORP (edgar:1126234) Free cash flow: -9090000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9090000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623421000034/nlnk-20201231.htm#1120905 Filing: 000112623421000034 Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623420000018/nlnk-20191231.htm#1860631 Filing: 000112623420000018 The citation records this snapshot. The page link may show a newer release later.
2021 2020-01-01 – 2020-12-31	−USD 5.66 million Exact value Exact value: -5663000 USD 2020-01-01 – 2020-12-31: -5663000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2020-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -5663000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5663000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623422000021/nlnk-20211231.htm#1553363 Filing: 000112623422000021 The citation records this snapshot. The page link may show a newer release later.	−USD 23 million Exact value Exact value: -22997000 USD 2020-01-01 – 2020-12-31: -22997000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2020-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -22997000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22997000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623422000021/nlnk-20211231.htm#1144153 Filing: 000112623422000021 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2021-01-01 – 2021-12-31	−USD 30.43 million Exact value Exact value: -30430000 USD 2021-01-01 – 2021-12-31: -30430000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2021-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -30430000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30430000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623423000035/nlnk-20221231.htm#1608317 Filing: 000112623423000035 The citation records this snapshot. The page link may show a newer release later.	−USD 29.65 million Exact value Exact value: -29648000 USD 2021-01-01 – 2021-12-31: -29648000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2021-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -29648000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29648000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623423000035/nlnk-20221231.htm#1197736 Filing: 000112623423000035 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2022-01-01 – 2022-12-31	−USD 31.06 million Exact value Exact value: -31062000 USD 2022-01-01 – 2022-12-31: -31062000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2022-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -31062000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31062000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1387400 Filing: 000112623424000025 The citation records this snapshot. The page link may show a newer release later.	−USD 26.62 million Exact value Exact value: -26623000 USD 2022-01-01 – 2022-12-31: -26623000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2022-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -26623000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26623000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1051811 Filing: 000112623424000025 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2023-01-01 – 2023-12-31	−USD 34.03 million Exact value Exact value: -34034000 USD 2023-01-01 – 2023-12-31: -34034000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEWLINK GENETICS CORP · 2023-12-31 NEWLINK GENETICS CORP (edgar:1126234) Net Income: -34034000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34034000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1386474 Filing: 000112623424000025 The citation records this snapshot. The page link may show a newer release later.	−USD 31.1 million Exact value Exact value: -31095000 USD 2023-01-01 – 2023-12-31: -31095000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEWLINK GENETICS CORP · 2023-12-31 NEWLINK GENETICS CORP (edgar:1126234) Operating Cash Flow: -31095000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:56:07Z Snapshot: c8844721238a17150f5c7259969a0b0ffd22b7c31ea3be7bd20a59c5a5b16dc5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1126234/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31095000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623424000025/nlnk-20231231.htm#1051155 Filing: 000112623424000025 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

104 filings · 3,947 latest values · 3,970 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001126234, 1126234, LUMO, NLNK, edgar:1126234

Also known as LUMOS PHARMA, INC., NEWLINK GENETICS CORP, NEWLINK GENETICS CORPORATION

NEWLINK GENETICS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2024 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation